Lipid regulating compositions

Details Lipid regulating compositions Lipid regulating compositions

1987-06-15

1989-08-22

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514537, 514563, 514571, 514627, 514824, 260DIG47, A61K 31235, A61K 3124, A61K 31195, A61K 3116

Patent

active

048597031

ABSTRACT:
Single dose formulations containing a combination of a lipid regulating agent selected from gemfibrozil, clofibrate, bezafibrate, or fenofibrate and an ACAT inhibiting agent are effective pharmacological formulations for regulating blood serum lipid and cholesterol levels.

REFERENCES:
patent: 3262850 (1966-07-01), Jones
patent: 3674836 (1972-07-01), Creger
patent: 3781327 (1973-12-01), Teach
patent: 3846541 (1984-11-01), Lachampt
patent: 3907792 (1975-09-01), Mieville
patent: 4751026 (1988-06-01), Hoefle et al.
M. S. Brown and J. L. Goldstein, New England Journal of Medicine, 305 (9): 515-517 (1981).
Saku et al., J. Clin. Invest., 75: 1702-1712 (1985).
Ottmar Leiss et al., Metabolism, 34 (1): 74-82 (1985).
S. M. Grundy et al., J. Lipid Res., 13: 531-551 (1972).
D. Pertsemlidis et al., Gastroenterology, 66: 565-573 (1974).
K. von Bergmann et al., Europ. J. Clin. Invest., 14: 150-154 (1984).

Affiliated with

Also associated with

Rating

Lipid regulating compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lipid regulating compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipid regulating compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2417925